Characteristics of rare ST463 carbapenem-resistant Pseudomonas aeruginosa clinical isolates from blood

被引:4
|
作者
Zhang, Xiaodong [1 ]
Tang, Miran [1 ]
Xu, Ye [2 ]
Xu, Mengxin [1 ]
Qian, Changrui [3 ]
Zheng, Xiangkuo [1 ]
Zhou, Tieli [1 ,4 ]
Wu, Qing [1 ,4 ]
机构
[1] Wenzhou Med Univ, Dept Clin Lab, Key Lab Clin Lab Diag & Translat Res Zhejiang Prov, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Southern Med Univ, Affiliated Hosp 5, Dept Clin Lab, Guangzhou, Peoples R China
[3] Wenzhou Med Univ, Sch Basic Med Sci, Wenzhou, Peoples R China
[4] Wenzhou Med Univ, Dept Clin, Key Lab Clin Lab Diag & Translat Res Zhejiang Prov, Affiliated Hosp 1, Wenzhou 325000, Peoples R China
关键词
bla KPC-2; bla OXA-486; Carbapenem-resistant Pseudomonas  aeruginosa; crpP; ST463; Virulence;
D O I
10.1016/j.jgar.2023.01.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: This study aimed to elucidate resistance to carbapenems and fluoroquinolones, the transmis-sion mechanism of blaKPC-2, and the virulence characteristics of a Pseudomonas aeruginosa strain (TL3773) isolated in East China.Methods: The virulence and resistance mechanisms of TL3773 were investigated by whole genome se-quencing (WGS), comparative genomic analysis, conjugation experiments, and virulence assays. Results: This study isolated carbapenem-resistant P. aeruginosa from blood resistant to carbapen-ems. The patient's clinical data showed poor prognosis compounded by multiple sites of infec-tion. WGS showed that TL3773 carried aph (3')-IIb, blaPAO, bla OXA-486, fosA, catB7, and two crpP re-sistance genes on chromosome, and the carbapenem resistance gene blaKPC-2 on plasmid. We iden-tified a novel crpP gene named TL3773-crpP2. Cloning experiments proved that TL3773-crpP2 was not the primary cause of fluoroquinolone resistance in TL3773. GyrA and ParC mutations may con-fer fluoroquinolone resistance. The blaKPC-2 genetic environment was IS26-TnpR-ISKpn27- blaKPC-2-ISKpn6- IS26-Tn3-IS26, potentially mediating the transmission of blaKPC-2 in P. aeruginosa. The overall vir-ulence of TL3773 was lower than that of PAO1. However, the pyocyanin and biofilm formation of TL3773 was higher than that of PAO1. WGS further indicated that TL3773 was less virulent than PAO1. Phylogenetic analysis showed that TL3773 was most similar to the P. aeruginosa isolate ZYPA29 from Hangzhou, China. These observations further indicate that ST463 P. aeruginosa is rapidly spreading.Conclusions: The threat of ST463 P. aeruginosa harbouring blaKPC-2 is emergent and may pose a threat to human health. More extensive surveillance and effective actions are urgently needed to control its further spread.(c) 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:122 / 130
页数:9
相关论文
共 50 条
  • [41] An 11-year experience of carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa bacteremia
    Cho, E.
    Choi, S. -H.
    Chung, J. -W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S98 - S98
  • [42] Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa
    Walsh, F.
    Amyes, S. G. B.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (04) : 376 - 381
  • [43] Dose optimization of piperacillin/tazobactam, cefepime, and ceftazidime for carbapenem-resistant Pseudomonas aeruginosa isolates in Turkiye
    Buyukyanbolu, Ecem
    Gill, Christian M.
    Genc, Leyla
    Karakus, Mehmet
    Comert, Fusun
    Otlu, Baris
    Aktas, Elif
    Nicolau, David P.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2025, 44 (01) : 159 - 165
  • [44] Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates
    Dalia Salem
    Ahmed El-Shenawy
    Heba Dahroug
    Manar Zaiton
    Doaa Gamal
    Manal Diab
    BMC Infectious Diseases, 25 (1)
  • [45] Microbiological Characteristics of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates Collected from County Hospitals
    Xie, Shujin
    Fu, Shiming
    Li, Mengwei
    Guo, Zhusheng
    Zhu, Xuehai
    Ren, Jianmin
    Hu, Fupin
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 1163 - 1169
  • [46] Risk Factors for Carbapenem-resistant Pseudomonas aeruginosa Infection in Children
    Li, Lu
    Huang, Yanfeng
    Tang, Qiqin
    Zheng, Yuqiang
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (08) : 642 - 647
  • [47] Activity of ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa
    Wi, Y. M.
    Greenwood-Quaintance, K. E.
    Ko, K. S.
    Kwon, K. T.
    Jung, S. -I.
    Kim, Y. -S.
    Kim, S. -W.
    Yeom, J. -S.
    Peck, K. R.
    Song, J. -H.
    Patel, R.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S124 - S125
  • [48] Evaluation of a Hospital Outbreak Related to Carbapenem-Resistant Pseudomonas aeruginosa
    Cekin, Yesim
    Karagoz, Alper
    Kizilates, Filiz
    Cekin, Ayhan Hilmi
    Oztoprak Cuvalci, Nefise
    Bulbuller, Nurullah
    Durmaz, Riza
    MIKROBIYOLOJI BULTENI, 2013, 47 (04): : 619 - 627
  • [49] Influence of ertapenem administration on the incidence of carbapenem-resistant Pseudomonas aeruginosa
    Lei Munhoz Lima, Ana Lucia
    Domingos Oliveira, Priscila Rosalba
    Paula, Adriana P.
    Zumiotti, Arnaldo Valdir
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (02): : 105 - 106
  • [50] INCIDENCE OF CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA IN DIABETES AND CANCER PATIENTS
    Varaiya, A.
    Kulkarni, M.
    Bhalekar, P.
    Dogra, J.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 26 (03) : 238 - 240